Skip to main content
OpenTrials
Active, not recruiting

NCT Number: NCT05404594

Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants

The management of pain related to venipuncture remains insufficient in very preterm infants (VPI. The separation between the mother (father) and her(his) child can aggravate the short-term painful experience of the newborn. Accurate diagnosis and treatment of pain is necessary to preserve the well-being and brain development of VPI. A better understanding of the development of pain pathways and the cortical integration of nociceptive messages is essential to reach this goal.

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

About this study

The primary objective of this study is to evaluate the maturation of hemodynamic cortical responses in VPI at different postmenstrual ages (PMAs) and Full term neonates in response to a stimulation of nociceptive pathways (potentially associated with a venipuncture realized with recommended non pharmacological pain treatment and required for clinical purpose) and to a control non noxious stimulation (skin contact) and to a cold non noxious stimulation.

The secondary objectives of the study protocol are:

  • To assess the maturation of neurophysiological, autonomic, and behavioral pain responses in VPI at different PMAs in response to the stimulation of nociceptive pathways
  • To evaluate the impact at corrected term age of early neonatal experience (repeated nociceptive stimulations in VPIs compared to term neonate) on hemodynamic, neurophysiological, autonomic and behavioral responses to nociceptive stimulation
  • To determine the existing correlations between cortical hemodynamic, neurophysiological, autonomic, and behavioral responses to pain in VPIs and term neonates.
  • To evaluate the maturation of conduction velocities of small caliber nociceptive fibers in response to a non-painful cold stimulation of A delta and C fibers
  • To evaluate the impact of the child's gender on the maturation of the nociceptive pathways and the pain behavior.
  • To evaluate the impact of early maternal separation on the maturation of nociceptive pathways and pain behavior of the child.
  • To evaluate the impact of an analgesic strategy using the mother's voice in addition to the usual non-pharmacological pain management strategies
  • To evaluate the potential mechanisms of action of exposure to the maternal voice, in particular whether this exposure modifies oxytocin secretion in the newborn

We make several hypotheses. The first is that there is a progressive maturation of the nociceptive systems with a modification of the cerebral responses with advancing gestational age (partly related to a modification of the nociceptive conduction velocities). Furthermore, we hypothesize that there is a global correlation between measured nociceptive cortical activation (Near infra Red Spectroscopy and evoked potentials) indicative of a "conscious" perception of pain and other pain indicators (physiological-autonomic and behavioral) for stimuli encountered by VPI during routine care. However, the possibility of a discrepancy between the responses measured by these different indicators exists in the literature. In this case, the analysis of the differences observed with the cortical hemodynamic responses considered as reference, will allow a better understanding of the incidence and the mechanisms of these discordances.

We also hypothesize that early experiences of VPI, in particular early maternal separation, may alter the development and function of nociceptive pathways and make the neonate more sensitive to pain.

Finally, we hypothesize that live maternal voice delivery may have an additional analgesic effect compared to the non-pharmacological strategies usually used for the treatment of neonatal pain during venipuncture.

The expected results of this study are an improved knowledge of the development of nociception in VPI, the clinical relevance of pain indicators, and a better understanding of the environmental factors that may modulate it. They should allow a better evaluation of pain in VPIs and an improvement in the management of pain related to venipuncture. They should also allow a better understanding of the potential mechanisms of action of the antalgic use of the maternal voice during a painful procedure in the newborn.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)
  • Control group: Healthy full-term babies (> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital
  • Consent obtained from both parents
  • Subject affiliated to a social health insurance plan.

Exclusion criteria

  • - Any malformation known before inclusion
  • Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)
  • Unstable clinical status according to the investigator's judgment
  • Expected transfer of the child to another hospital before the term of 40 weeks PMAs.

Treatment and study plan

Maternal vocal contact

Behavioral

Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant.

In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Primary outcomes

  1. The cortical hemodynamic response profile(changes in oxyhemoglobin levels in the somato-sensory areas) in response to venipuncture performed with a recommended standard nonpharmacological analgesic treatment (non-nutritive sucking, and sweet solution)

    Time frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI and at 2 to 3 days of life in term neonates.

    The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: NOCI-Prem

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
Jun 3, 2022
Registry last updated
Aug 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.